For Immediate Release

The report sheds light on timely trends and issues for manufacturers like regulatory complexity, workforce challenges and automation

SAN DIEGO, Calif., April 2, 2025 – Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical and life science devices that provides total commercialization services from ideation to scaled manufacturing, today announced the release of its latest State of the Industry Report, titled “Automate, Innovate, Adapt: The 2025 State of Medical & Life Sciences Manufacturing.” Leveraging exclusive survey data and expert analysis, the report provides a comprehensive look at key trends, challenges and opportunities shaping the future of medical and life sciences manufacturing. It also offers practical advice and solutions for organizations looking to drive innovation and operational excellence today. 

Key survey data and insights from the report include: 

• Automation Adoption is Growing but Faces Integration Hurdles – While 69% of survey respondents have implemented some form of automation, only 9% have fully integrated it across their operations.
• Regulatory Challenges Continue to Hinder Commercialization – 42% of respondents cite regulatory compliance as the top barrier to commercializing medical products.
• Personalized Medicine is a Rising Challenge – Almost 31% of survey participants identified personalized medicine as the most challenging manufacturing trend in 2025.
• Reshoring Efforts Face Economic Barriers – 56% of respondents identified high labor and operational costs as the primary obstacles to bringing manufacturing back to their home countries, a critical concern given uncertainties around tariffs.

“The medical and life sciences manufacturing sector is at the forefront of global healthcare innovation. As it continues to evolve, companies must learn to navigate a complex landscape of supply chain disruptions, ongoing technological advancements and increasing regulatory demands,” said Anupam Girdhar, CEO of Ascential Medical & Life Sciences. “As a trusted partner to many organizations in this industry, we fully understand today’s primary challenges and, perhaps more importantly, what companies must do to achieve success. With this, we’ve incorporated key opportunities and actionable takeaways and best practices into the report.” 

A few of those key opportunities include:

• By combining technology evaluation, scalability planning and continuous improvement, manufacturers can overcome commercialization obstacles.
• With highly tailored solutions, medical and life sciences companies can embrace automation at their own pace, ensuring success in an increasingly automated industry.
• The future of supply chain optimization lies in regional supply chains, not solely in reshoring. Positioning operations near key customer hubs and embracing a nearshoring approach can balance cost efficiency with risk mitigation.

Designed to be a resource for professionals across the medical and life sciences sector, the report indicates that the future of the industry will be defined by companies that embrace change and prioritize innovation and strategic collaboration.

To access the full State of the Industry Report, please visit here. For additional information on Ascential Medical & Life Sciences, please visit ascentialtech.com/mls/. 

About Ascential Medical & Life Sciences
Ascential Medical & Life Sciences designs, develops, and automates complex products from ideation to scaled manufacturing, tackling customers’ most demanding, mission-critical challenges where the cost of failure is high. It brings together over 70 years of expertise through the strategic acquisitions of leading specialized businesses which now operate as a single integrated entity. Deep expertise and experience of various trusted companies such as Korvis, D&K Engineering, Kinematic and NACS, have been brought together to serve a broad range of customers including Blue-chips, Mid-Market and Start-ups across Medical Devices, Life Sciences, Pharmaceuticals and Healthcare. The company helps customers accelerate critical solution innovation, mitigate risk, drive competitive differentiation, and shorten time to market, at scale. Ascential’s uniqueness lies in its commitment to guiding customers through the entire product life cycle, from ideation to commercialization, where quality and safety matter most. Ascential customers include Fortune 100 leaders and disruptive innovators such as 3M, Abbott, Boston Scientific, Medtronic, and Thermo Fisher Scientific. Learn more at https://mls.ascentialtech.com/.  

About Ascential Technologies
Ascential Technologies, (formerly known as Burke Porter Group), designs, develops, and automates complex diagnostics, inspection and test processes across medical & life sciences, transportation, and test & measurement systems end markets. The company tackles customers’ most demanding, mission-critical challenges where the cost of failure is high. With more than 70 years of innovation experience, Ascential has a global presence and the expertise of more than 2,300 professionals across 40 locations, helping customers accelerate critical solution innovation, mitigate risk, drive competitive differentiation, and shorten time to market, at scale. The company’s uniqueness lies in its commitment to guiding customers through the entire product life cycle, from ideation to commercialization, where quality and safety matter most. Ascential’s customers include Fortune 100 leaders and disruptive innovators. Learn more at mls.ascentialtech.com. 

Editorial Contacts
Agency:
Brittney Popa
MBE Group on behalf of Ascential Technologies
231-675-1692
[email protected]

Mike Bleau
Industry Scope on behalf of Ascential Technologies
(810) 397-1429
[email protected] 

Related:

Press Release Related

Ascential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic Growth

More

Blog Related

Cell Therapy Manufacturing Services: Reducing Time to Market with Automation

More